Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Castle Creek Biosciences: Cell and Gene Therapy Company : Castle Creek Biosciences, |
Description | Dedicated to making life better for people living with genetic Dedicated to making life better for people suffering from rare diseases with few or no treatment |
Keywords | N/A |
WebSite | castlecreekpharma.com |
Host IP | 3.33.152.147 |
Location | United States |
Site | Rank |
US$910
Last updated: 2023-05-12 20:08:27
castlecreekpharma.com has Semrush global rank of 0. castlecreekpharma.com has an estimated worth of US$ 910, based on its estimated Ads revenue. castlecreekpharma.com receives approximately 105 unique visitors each day. Its web server is located in United States, with IP address 3.33.152.147. According to SiteAdvisor, castlecreekpharma.com is safe to visit. |
Purchase/Sale Value | US$910 |
Daily Ads Revenue | US$0 |
Monthly Ads Revenue | US$25 |
Yearly Ads Revenue | US$302 |
Daily Unique Visitors | 7 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
castlecreekpharma.com. | A | 600 | IP: 3.33.152.147 |
castlecreekpharma.com. | A | 600 | IP: 15.197.142.173 |
castlecreekpharma.com. | NS | 3600 | NS Record: ns45.domaincontrol.com. |
castlecreekpharma.com. | NS | 3600 | NS Record: ns46.domaincontrol.com. |
castlecreekpharma.com. | MX | 600 | MX Record: 10 us-smtp-inbound-2.mimecast.com. |
castlecreekpharma.com. | MX | 600 | MX Record: 10 us-smtp-inbound-1.mimecast.com. |
castlecreekpharma.com. | TXT | 600 | TXT Record: google-site-verification=Kue3T2W80CHZi6jhrhO10BspyLbTyzbd7-Z3pH7sKHI |
castlecreekpharma.com. | TXT | 600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
castlecreekpharma.com. | TXT | 600 | TXT Record: MS=ms95814346 |
castlecreekpharma.com. | TXT | 600 | TXT Record: v=verifydomain MS=6978896 |
About Leadership Community Outreach Careers Contact Us Technology Lenti-VEX™ Delivery Platform Lenti-VO™ Delivery Platform Manufacturing Publications Pipeline & Clinical Trials D-Fi Gene Therapy for Dystrophic Epidermolysis Bullosa (DEB) LV-FAH Gene Therapy for Hereditary Tyrosinemia Type 1 (HT1) Clinical Trials Patients & Families Epidermolysis Bullosa (EB) Tyrosinemia Newsroom Press Releases Events & Presentations Media Coverage Contact Us Toggle navigation Dedicated to making life better for people living with genetic diseases Learn More Developing novel gene therapies by using lentiviral vector delivery platforms Learn More Pursuing multiple indications in parallel by switching gene targets to create optimal therapies for a broad range of genetic diseases Learn More "We are building a leading lentiviral-based cell and gene therapy company using our versatile dual technology platform and in-house manufacturing capabilities to advance development of potentially transformative |
HTTP/1.1 405 Not Allowed Server: awselb/2.0 Date: Sun, 19 Dec 2021 22:41:14 GMT Content-Length: 0 Connection: keep-alive WAFRule: HTTPMethodNOTAllowed |
Domain Name: CASTLECREEKPHARMA.COM Registry Domain ID: 1954977035_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-08-25T16:25:27Z Creation Date: 2015-08-24T16:26:09Z Registry Expiry Date: 2022-08-24T16:26:09Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS45.DOMAINCONTROL.COM Name Server: NS46.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-23T07:27:59Z <<< |